The SYFAIT Case: Competition and Regulatory Aspects of Parallel Trade
This article was originally published in SRA
Executive Summary
Maarten Meulenbelt discusses the long-awaited decision by the Greek competition authorities in SYFAIT's parallel trade case against GlaxoSmithKline.